Anika Therapeutics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ANIK Nasdaq 3840 www.anika.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anika Therapeutics, Inc.

Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference - Mar 3rd, 2026 1:29 am
Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Highlights: Strong International Growth and ... - Feb 26th, 2026 2:09 pm
Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates - Feb 26th, 2026 10:15 am
Anika Therapeutics Q4 Earnings Call Highlights - Feb 26th, 2026 8:59 am
Anika: Q4 Earnings Snapshot - Feb 26th, 2026 5:35 am
Anika Reports Fourth Quarter and Full Year 2025 Financial Results - Feb 26th, 2026 5:05 am
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference - Feb 18th, 2026 2:01 pm
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026 - Feb 12th, 2026 2:01 pm
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors - Feb 4th, 2026 6:54 am
Anika Therapeutics Announces Leadership Transition - Jan 8th, 2026 5:00 am
Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 39%? - Dec 3rd, 2025 3:15 am
Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Call Highlights: Strong Growth in Regenerative ... - Nov 6th, 2025 4:00 pm
Anika Therapeutics (ANIK) Trades Below Fair Value; Valuation Discount Reinforces Cautious Market Narratives - Nov 5th, 2025 6:13 pm
Anika (ANIK) Q3 2025 Earnings Call Transcript - Nov 5th, 2025 7:17 am
Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates - Nov 5th, 2025 6:25 am
Anika: Q3 Earnings Snapshot - Nov 5th, 2025 5:22 am
Anika Reports Third Quarter 2025 Financial Results - Nov 5th, 2025 5:05 am
Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study - Nov 5th, 2025 5:00 am
Anika Therapeutics, Inc. (NASDAQ:ANIK) is a favorite amongst institutional investors who own 60% - Oct 28th, 2025 10:22 am
Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 - Oct 23rd, 2025 2:01 pm